1. Home
  2. NLSP vs VERB Comparison

NLSP vs VERB Comparison

Compare NLSP & VERB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NLSP
  • VERB
  • Stock Information
  • Founded
  • NLSP 2015
  • VERB 2014
  • Country
  • NLSP Switzerland
  • VERB United States
  • Employees
  • NLSP N/A
  • VERB N/A
  • Industry
  • NLSP Biotechnology: Pharmaceutical Preparations
  • VERB Other Consumer Services
  • Sector
  • NLSP Health Care
  • VERB Consumer Discretionary
  • Exchange
  • NLSP Nasdaq
  • VERB Nasdaq
  • Market Cap
  • NLSP 5.8M
  • VERB 5.8M
  • IPO Year
  • NLSP 2021
  • VERB N/A
  • Fundamental
  • Price
  • NLSP $2.30
  • VERB $8.98
  • Analyst Decision
  • NLSP
  • VERB Strong Buy
  • Analyst Count
  • NLSP 0
  • VERB 1
  • Target Price
  • NLSP N/A
  • VERB $62.00
  • AVG Volume (30 Days)
  • NLSP 423.9K
  • VERB 111.7K
  • Earning Date
  • NLSP 06-17-2025
  • VERB 05-13-2025
  • Dividend Yield
  • NLSP N/A
  • VERB N/A
  • EPS Growth
  • NLSP N/A
  • VERB N/A
  • EPS
  • NLSP N/A
  • VERB N/A
  • Revenue
  • NLSP N/A
  • VERB $2,193,000.00
  • Revenue This Year
  • NLSP N/A
  • VERB $287.49
  • Revenue Next Year
  • NLSP N/A
  • VERB $47.06
  • P/E Ratio
  • NLSP N/A
  • VERB N/A
  • Revenue Growth
  • NLSP N/A
  • VERB 3125.00
  • 52 Week Low
  • NLSP $1.30
  • VERB $3.81
  • 52 Week High
  • NLSP $18.39
  • VERB $30.98
  • Technical
  • Relative Strength Index (RSI)
  • NLSP 65.15
  • VERB 73.50
  • Support Level
  • NLSP $1.58
  • VERB $5.94
  • Resistance Level
  • NLSP $2.39
  • VERB $8.49
  • Average True Range (ATR)
  • NLSP 0.23
  • VERB 0.67
  • MACD
  • NLSP 0.02
  • VERB 0.23
  • Stochastic Oscillator
  • NLSP 89.29
  • VERB 83.31

About NLSP NLS Pharmaceutics Ltd.

NLS Pharmaceutics Ltd is a biopharmaceutical company. It is engaged in the discovery and development of life-improving drug therapies to treat rare and complex CNS disorders. It focuses on developing therapeutics for the treatment of neurobehavioral and neurocognitive disorders. The company's tangible assets are held in the United States. Its lead products are Quilience, to treat narcolepsy and Nolazol, to treat ADHD.

About VERB Verb Technology Company Inc.

Verb Technology Co Inc leader in interactive video-based sales applications, transforms how businesses attract and engage customers. VERB's Software-as-a-Service platform, based on its proprietary interactive video technology, comprises a suite of easy-to-use, subscription-based sales enablement software products. The segments of the company are MARKET.live and Go Fund Yourself, and it derives maximum revenue from MARKET.live segment.

Share on Social Networks: